High-quality flow cytometry services for clinical trials—cell characterization, immunophenotyping, and biomarker analysis you can trust.
With our Centers of Excellence and global lab network, we deliver scalable, high-quality solutions backed by expert scientific & regulatory support.
With synchronized platforms and expert teams across three continents, we deliver scalable, end‑to‑end support for biomarker and immunology programs worldwide. Our harmonized platforms ensure consistent panel performance, reproducible data, and seamless study execution regardless of testing location.
Our platforms include:
Agilent NovoCyte Quanteon, 4-laser, 25-color
BD FACSCanto II Flow Cytometer, 3-laser, 8-color
BD FACSymphony A5, Spectrally enabled, 5-laser, 48-color
Advanced sample testing capabilities
Expertise in assay development and validation
Specialized focus areas:
Phenotyping
Functional Assays
CAR-T
Receptor Occupancy
ADA/NAb
Ex vivo stimulation with tumor-associated and viral antigens
Intracellular cytokine detection
Tetramer staining
Signaling analysis (phosphorylation, acetylation)
B cell and NK cell subsets
T cell exhaustion, activation, checkpoint markers
T cell maturation and subsets
Monocyte profiling
Cellular kinetics (engineered cells, CAR-T cells)
Immunogenicity testing (ADA/NAb)
Receptor occupancy assays
Regulated environments: CAP/CLIA, GCLP, GLP/GLP-like compliant
Specimen types: Whole blood, bone marrow, cryopreserved PBMCs, tissue samples
Assay development & validation: Fully aligned with CLSI H62 standards
Rapid turnaround and support for limited stability samples
Led by Virginia Litwin, Ph.D., Director of Scientific Affairs:
President-Elect, International Society for the Advancement of Cytometry
2023 Wallace H. Coulter Award recipient
Chair, CLSI H62 and H42
Co-founder, AAPS Flow Cytometry Committee
Member NIST Flow Cytometry Standards Consortium
Learn more about our current capabilities and future plans in our Flow Cytometry Services for Clinical Trials brochure.